Marona-Lewicka D, Nichols D E
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN 47907, USA.
Neuropharmacology. 1997 Oct;36(10):1471-5. doi: 10.1016/s0028-3908(97)00106-8.
The possible effect of 5-HT2A/2C receptor agonists on an amphetamine-induced behavioral response was examined using the two-lever drug discrimination paradigm. The experiments were designed to investigate an interaction of the hallucinogenic 5-HT2A/2C agonists lysergic acid diethylamide (LSD) and 2,5-dimethoxy-4-iodoamphetamine (DOI), with the discriminative stimulus elicited by a relatively low dose of (+)-amphetamine (1.35 micromol/kg, 0.25 mg/kg, which produced approximately 50% selection of the drug lever). DOI and LSD did not produce amphetamine-like responding at any dose tested or time of administration. However, LSD alone was able to induce a drug-appropriate response in two of nine amphetamine-trained rats. Simultaneous administration of DOI or LSD with amphetamine was not significantly different from the response produced by amphetamine alone. Pre-administration of DOI (3 hr) or of LSD (2 hr) before amphetamine, however, evoked significant enhancement of the amphetamine cue. The results suggest that the enhanced behavioral response to amphetamine may be due either to an increased sensitivity of dopaminergic neurons in the mesolimbic area, or to an enhanced release of dopamine by amphetamine.
使用双杠杆药物辨别范式研究了5-羟色胺2A/2C受体激动剂对苯丙胺诱导的行为反应的可能影响。实验旨在研究致幻性5-羟色胺2A/2C激动剂麦角酸二乙酰胺(LSD)和2,5-二甲氧基-4-碘苯丙胺(DOI)与相对低剂量的(+)-苯丙胺(1.35微摩尔/千克,0.25毫克/千克,该剂量产生约50%的药物杠杆选择率)引发的辨别性刺激之间的相互作用。DOI和LSD在任何测试剂量或给药时间均未产生类似苯丙胺的反应。然而,单独使用LSD能够在9只经苯丙胺训练的大鼠中的2只中诱导出药物适当反应。DOI或LSD与苯丙胺同时给药与单独使用苯丙胺产生的反应无显著差异。然而,在苯丙胺给药前3小时给予DOI或2小时给予LSD,会显著增强苯丙胺线索。结果表明,对苯丙胺行为反应增强可能是由于中脑边缘区域多巴胺能神经元敏感性增加,或者是由于苯丙胺导致多巴胺释放增加。